{"id":396779,"date":"2025-04-15T01:05:00","date_gmt":"2025-04-14T23:05:00","guid":{"rendered":"https:\/\/medizinonline.com\/le-daratumumab-retarde-la-progression-du-myelome-multiple-de-smoldering\/"},"modified":"2025-04-14T21:39:45","modified_gmt":"2025-04-14T19:39:45","slug":"le-daratumumab-retarde-la-progression-du-myelome-multiple-de-smoldering","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/le-daratumumab-retarde-la-progression-du-myelome-multiple-de-smoldering\/","title":{"rendered":"Le daratumumab retarde la progression du my\u00e9lome multiple de Smoldering"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Le my\u00e9lome multiple \u00e0 cellules smoldering (SMM) est un pr\u00e9curseur pr\u00e9maligne asymptomatique du my\u00e9lome multiple actif (MM). Les r\u00e9sultats de l&#8217;\u00e9tude de phase III AQUILA pr\u00e9sent\u00e9s ici montrent que le daratumumab retarde significativement l&#8217;\u00e9volution du SMM vers un my\u00e9lome multiple actif (MM) chez les patients \u00e0 haut risque. <\/strong><\/p>\n\n\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fle-daratumumab-retarde-la-progression-du-myelome-multiple-de-smoldering%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Le my\u00e9lome multiple \u00e0 cellules smoldering (SMM) est un pr\u00e9curseur pr\u00e9maligne asymptomatique du my\u00e9lome multiple actif (MM). Les r\u00e9sultats de l&#8217;\u00e9tude de phase III AQUILA pr\u00e9sent\u00e9s ici montrent que le&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fle-daratumumab-retarde-la-progression-du-myelome-multiple-de-smoldering%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":396784,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"My\u00e9lome multiple avec smoldering","footnotes":""},"category":[11549,11373,11389,11535],"tags":[81782,38597,81854,81852,81853],"powerkit_post_featured":[],"class_list":["post-396779","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-hematologie","category-oncologie","category-rapports-de-congres","tag-ash-2024-fr","tag-daratumumab-fr","tag-myelome-multiple-avec-smoldering","tag-myelome-multiple-smoldering","tag-smm-fr","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-18 16:01:54","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":396773,"slug":"daratumumab-ritarda-la-progressione-nel-mieloma-multiplo-smoldering","post_title":"Daratumumab ritarda la progressione nel mieloma multiplo smoldering","href":"https:\/\/medizinonline.com\/it\/daratumumab-ritarda-la-progressione-nel-mieloma-multiplo-smoldering\/"},"pt_PT":{"locale":"pt_PT","id":396768,"slug":"daratumumab-atrasa-a-progressao-no-mieloma-multiplo-latente","post_title":"Daratumumab atrasa a progress\u00e3o no mieloma m\u00faltiplo latente","href":"https:\/\/medizinonline.com\/pt-pt\/daratumumab-atrasa-a-progressao-no-mieloma-multiplo-latente\/"},"es_ES":{"locale":"es_ES","id":396763,"slug":"el-daratumumab-retrasa-la-progresion-en-el-mieloma-multiple-latente","post_title":"El daratumumab retrasa la progresi\u00f3n en el mieloma m\u00faltiple latente","href":"https:\/\/medizinonline.com\/es\/el-daratumumab-retrasa-la-progresion-en-el-mieloma-multiple-latente\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/396779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=396779"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/396779\/revisions"}],"predecessor-version":[{"id":398249,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/396779\/revisions\/398249"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/396784"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=396779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=396779"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=396779"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=396779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}